AI assistant
STAR COMBO PHARMA LIMITED — Capital/Financing Update 2021
Nov 3, 2021
65746_rns_2021-11-03_5e49b399-eb8e-45db-8d9b-d9ff8e5a88c7.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [115 x 40] intentionally omitted <==
STAR COMBO PHARMA LTD ABN 38 6157 283 75 171 -177 Woodpark Rd Smithfield NSW 2164 P: +61 2 9756 6555 [email protected]
4 November 2021 ASX Announcement
Star Combo wins $5.0M order with a leading Australian health supplement brand
- Star Combo receives $5.0M order, its largest OEM order to date, from a leading Australian health supplement brand
Star Combo Pharma Limited (ASX: S66) (Star Combo) announced today that it has received a $5.0M order, its largest OEM order to date from a leading Australian health supplement brand for the manufacturing of approximately 290 million bulk capsules to be completed by the end of third quarter of 2022 financial year, a positive start to the second quarter of 2022 financial year.
Star Combo’s manufacturing relationship with this supplement brand has been strengthening over the last 12 months and Star Combo anticipates further orders in the future following the brand’s review of its long-term strategy. The supplement brand is now seeking manufacturing capabilities not previously required.
Commenting, Star Combo’s CEO Su Zhang said, “We are delighted to see our contract manufacturing business moving to a new stage of growth as we roll out our enhanced manufacturing offering to an expanded customer base. We now have an established reputation in the market which has opened up new opportunities for us. We look forward to continuing to deliver premium products and growing our relationships both domestically and internationally as favorable macro trends help drive growth.
-ENDS-
This ASX announcement has been approved by the Star Combo Pharma’s Board of Directors.
Investor relations contact
Su Zhang - CEO
Media relations contact
WE Communications Kate Burrell T: 0438 680 628 [email protected]
About Star Combo Pharma
Star Combo Pharma Ltd (ASX: S66) is a Sydney based contract manufacturer of vitamins, health and beauty products with a portfolio of own brands and distribution capabilities. Our products are made from natural ingredients with scientific R&D and adheres to the highest manufacturing practices governed by the Therapeutic Goods Administration. Star Combo has offices in China and currently supplies the Australian pharmacy network through 450 Terry White Chemmart stores as well as wholesale customers in Australia and China. Directed by pharmacist and experts in health supplement manufacturing, Star Combo's vision is to be the leading manufacturer of premium vitamins and dietary supplements in Australia. Since its establishment in 2004, Star Combo has demonstrated strong product and business development and continues to expand our current operations to serve our loyal business partners, customers and employees.